American Century Companies Inc Puma Biotechnology, Inc. Transaction History
American Century Companies Inc
- $157 Billion
- Q1 2025
A detailed history of American Century Companies Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,149,660 shares of PBYI stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,149,660
Previous 948,376
21.22%
Holding current value
$4.05 Million
Previous $2.89 Million
17.63%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PBYI
# of Institutions
116Shares Held
30.9MCall Options Held
32.7KPut Options Held
200-
Acorn Capital Advisors, LLC New York, NY3.94MShares$13.9 Million8.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$12.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$12.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$7.07 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$6.44 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $160M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...